NCT06163508Enrolling by invitation
A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells
A Long Term Follow-Up Study for Subjects Who Have Received Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) (LTFU Study)
Source: ClinicalTrials.gov · Last updated 21 Apr 2026
Brief summary (registry, in English)
This study is an observational study designed to obtain information on the long-term safety, tolerability, and continued activity of Q-Cells®. The study will follow the participants who previously received Q-Cells® for 10 years. The goal of this observational study is to learn about the long term effects of Q-Cells® in people with transverse myelitis. The main objectives the study is to evaluate the safety of patients who have received Q-Cells®. The secondary goal of the study is to get data about the long-term activity of Q-Cells® over a period of 10 years. Patients will complete exams, lab tests, imaging, and questionnaires to monitor their safety.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 9 (estimated)
- First submitted
- 14 Nov 2023
- Start date
- 12 Dec 2023
- Primary completion date
- Dec 2035
- Lead sponsor
- University of Texas Southwestern Medical Center
- NCT number
- NCT06163508
What you commit to
- Study type: Observational
- Planned participants: 9
- From 12 Dec 2023 to the primary completion date, Dec 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. The study is intended to follow all subjects who have received Q-Cells® without exception.
Who the study is looking for
- Subjects must have been administered Q-Cells® as part of Protocol QTM-101 or other treatment Protocol.
- Subjects must have the ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to collect and use protected health information (PHI) in accordance with national and local subject privacy regulations.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.